USA flag logo/image

An Official Website of the United States Government

Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R44GM077753
Solicitation Year:
2012
Solicitation Topic Code:
NIGMS
Solicitation Number:
PA11-096
Small Business Information
AFFINERGY ,INC
BOX 14650, 617 DAVIS DR STE 100 RESEARCH TRIANGLE PARK, NC -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2012
Title: Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells
Agency: HHS
Contract: 2R44GM077753-04
Award Amount: $1,479,035.00
 

Abstract:

DESCRIPTION (provided by applicant): Autologous stem cells and growth factors provide valuable therapies for a variety of indications. When stem cells and growth factors are co-delivered, they produce a greater therapeutic effect than delivery of either stem cells or growth factors alone. However, the use of growth factors in the clinic is limited by the challenges of retaining the proteins at the site of healing. The use of stem cells is challenging because of the low frequency of cells in autologous tissue. To address these difficulties, Affinergy used its core technology, phage display biopanning, to screen phage libraries containing billions of candidate peptide sequences. From this process, we identified peptides that bind with high affinity and specificity to growth factors and stem cells. In our Phase II project, we developed a biomaterial coated with a growth factor-binding peptide that captures and retains growth factors significantly longer than the commercially available biomaterials. We demonstrated in animal models that this biomaterial has greater therapeutic efficacy than commercially available products when combined with autologous tissue containing the target growth factor. In this Competing Renewal application, we propose to further enhancethe efficacy of this product through the addition of a stem cell-binding peptide, also identified by phage display. The combination of the two peptides will increase the capture of stem cells from autologous tissue onto the material and provide a synergistic effect with the capture and retention of growth factors. PUBLIC HEALTH RELEVANCE: Stem cells and growth factors provide valuable therapies for a variety of indications, and co-delivery of stem cells with growth factors produces a greater therapeutic effect than delivery of either stem cells or growth factors alone. In this application, we propose to develop a biomaterial that can bind and retain both growth factors and stem cells.

Principal Investigator:

Shrikumar A. Nair
919-433-2268
snair@affinergy.com

Business Contact:

Chris Brasfield
919-433-2227
cbrasfield@affinergy.com
Small Business Information at Submission:

AFFINERGY, LLC
BOX 14650, 617 DAVIS DR STE 100 RESEARCH TRIANGLE PARK, NC -

EIN/Tax ID: 145356792
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No